183 related articles for article (PubMed ID: 35004767)
1. Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma.
Wang T; Wen W; Liu H; Zhang J; Zhang X; Wang Y
Front Med (Lausanne); 2021; 8():793401. PubMed ID: 35004767
[No Abstract] [Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
4. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
5. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
Li X; Lei Y
Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
[TBL] [Abstract][Full Text] [Related]
6. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
Liu Z; Liu H; Wang Y; Li Z
BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
[TBL] [Abstract][Full Text] [Related]
7. A Prognostic Signature Constructed by
Han S; Zhu W; Yang W; Guan Q; Chen C; He Q; Zhong Z; Zhao R; Xiong H; Han H; Li Y; Sun Z; Hu X; Tian J
Front Genet; 2021; 12():646818. PubMed ID: 34512711
[TBL] [Abstract][Full Text] [Related]
8. A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes.
Guan E; Tian F; Liu Z
Oncol Lett; 2020 Feb; 19(2):1351-1367. PubMed ID: 31966067
[TBL] [Abstract][Full Text] [Related]
9. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
10. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
Du Y; Wang Z; Wan W
J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
[No Abstract] [Full Text] [Related]
11. Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma.
Sun D; Zhang H; Zhang C
Front Pharmacol; 2023; 14():1185418. PubMed ID: 37284310
[No Abstract] [Full Text] [Related]
12. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.
Zhang K; Wang J; Zhu Y; Liu X; Li J; Shi Z; Cao M; Li Y
Front Oncol; 2022; 12():844990. PubMed ID: 35686089
[TBL] [Abstract][Full Text] [Related]
14. Development of a prognostic metabolic signature in stomach adenocarcinoma.
Gong Y; Wu S; Dong S; Chen S; Cai G; Bao K; Yang H; Jiao Y
Clin Transl Oncol; 2022 Aug; 24(8):1615-1630. PubMed ID: 35355155
[TBL] [Abstract][Full Text] [Related]
15. Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma-a study based on integrated bioinformatics analysis in GEO and TCGA database.
Song D; Tian J; Hu Y; Wei Y; Lu H; Wang Y; Guan Q; Zhou Y
Medicine (Baltimore); 2020 Dec; 99(51):e23605. PubMed ID: 33371094
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
17. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
18. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
[TBL] [Abstract][Full Text] [Related]
20. Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
Liu Q; Zhang W; Wu Z; Liu H; Hu H; Shi H; Li S; Zhang X
J Cell Biochem; 2020 Feb; 121(2):1317-1331. PubMed ID: 31486138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
